**Registered number: 08229467 Charity number: 1152591**
## **HAEUK**
**(A company limited by guarantee)**
## **UNAUDITED**
**TRUSTEES' REPORT AND FINANCIAL STATEMENTS**
**FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **HAEUK**
## **(A company limited by guarantee)**
## **CONTENTS**
||Page|
|---|---|
|**Reference and administrative details of the company, its Trustees and advisers**|1|
|**Trustees' report**|2 - 6|
|**Independent examiner's report**|7|
|**Statement of financial activities**|8|
|**Balance sheet**|9 - 10|
|**Notes to the financial statements**|11 - 21|
**(A company limited by guarantee)**
## **HAEUK**
## **REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **Trustees**
Ann Marie Harding, Chair Rosemary Frances Joseph, Treasurer June Cole, Trustee Dr Timothy Crouch, Trustee Barrie Sidney Hurley, Trustee Simon Jeremy Mumford, Trustee Dana Shapiro, Trustee
## **Company registered number**
08229467
## **Charity registered number**
1152591
## **Registered office**
2 Sheridan Close Bridgwater Somerset TA6 5SN
## **Accountants**
GMBC LLP Chartered Tax Advisers and Accountants Marine House 151 Western Road Haywards Heath West Sussex RH16 3LH
Page 1
**HAEUK**
**(A company limited by guarantee)**
## **TRUSTEES' REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2023**
The Trustees present their annual report together with the financial statements of the company for 1 October 2022 to 30 September 2023. The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).
Since the company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
## **Objectives and activities**
## **a. Policies and objectives**
The main purpose of the charity is to promote and protect the physical and mental health of sufferers of Hereditary Angioedema in the United Kingdom through the provision of support, education and practical advice and to advance the education of the general public in all areas of the condition.
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.
## **b. Activities undertaken to achieve objectives**
HAEUK has identified the following activities to promote the achievement of its objectives:
- . To ensure the UK has the highest possible standards of treatment for HAE
- . To provide patient advocacy and support, arranging periodic Patient Meetings, and maintaining and enhancing the website.
- . To make representations on various NHS consultation processes and to medical professionals and their professional bodies.
- . To commission the production and dissemination of best practice documentation for the management of HAE.
Page 2
**(A company limited by guarantee)**
## **HAEUK**
**TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **Achievements and performance**
## **a. Review of activities**
HAEUK was incorporated on 26th September 2012 and registered as a charity in England and Wales on 25 June 2013. The charity has more than 700 patients and carers on its database and continues to provide information, advocacy and support to both them and newly diagnosed patients through its website, through patient contact over the telephone and by providing speakers to attend patient days at individual hospitals. Patients also value the opportunity to share their experiences via the confidential Facebook page.
Various publications were produced/updated, included the information booklet " Understanding Hereditary Angioedema and acquired C1-Inhibitor Deficiency" and the leaflet " Supporting Us" which indicates ways in which individuals can donate to HAEUK, including through its JustGiving account. Many other publications were also revised and reprinted for circulation to immunology centres and patients around the country.
The Annual Patient Day was held in London with more than 60 delegates attending, together with consultant immunologists and specialist nurses. Presentations included the optimum management of HAE, home therapy and quality of life issues, as well as a forum for patients to discuss current issues around their personal HAE management plans.
HAEUK was represented at regional hospital patient days, at the Immunology and Allergy Nurses Conference and at the UK PIN conference.
HAEUK continues to work closely with Genetic Alliance and Rare Disease UK in maintaining a top-level dialogue with the Department of Health. The trustees were also represented by CEO at Rare Disease Day event at UK Parliament.
The Chief Executive Officer (CEO) was formally appointed with responsibilities to the Trustees for the day to day operational management of HAEUK and to take the organisation forward in the context of its Strategic Plan. The CEO continues to represent patient interests on the NHS England Clinical Review Group. The CEO is also on the GRC for immunology and Allergy specification working group and the PPV representative for revised service specifications.
HAEUK is a member of HAE International and participated in World HAE Awareness Day on 16th May 2023 as a means of connecting with the wider HAE community and to raise awareness generally.
## **b. Fundraising activities and income generation**
The primary source of income remains donations from pharmaceutical companies following submission of the necessary business plans to them. Other funding includes Foundation and members fundraising events.
## **Financial review**
## **a. Going concern**
After making appropriate enquiries, the Trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.
Page 3
**(A company limited by guarantee)**
## **HAEUK**
**TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **b. Reserves policy**
It is the policy of the Trustees to maintain a level of reserves sufficient to cover 3 months anticipated expenditure. At 30 September 2023 the level of reserves was consistent with this policy.
## **c. Principal funding**
Donations from pharmaceutical companies remains the primary source of funding. However have secured additional funding from a Foundation Trust.
Page 4
**(A company limited by guarantee)**
## **HAEUK**
## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **Structure, governance and management**
## **a. Constitution**
HAEUK is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association.
It is exempt from the use of the word 'limited'.
## **b. Methods of appointment or election of Trustees**
The management of the company is the responsibility of the Trustees who are elected and co-opted under the terms of the Articles of Association.
## **Plans for future periods**
HAEUK will continue to encourage patients and the wider public to fundraise eg, by way of donations, sponsorship, and regular/payroll giving in order to broaden the scope of its funding sources.
HAEUK will to update/produce a range of policies to formalize its operating arrangements etc; together with developing a secure data storage/filing system.
A comprehensive update of its website will be finalized, including working towards a specific member's only section.
HAEUK will aim to focus more on the needs of children and young people and envisage that volunteers will play an increasing role in this process.
HAEUK is proposing to extend its influence and support to patients in other parts of the United Kingdom.
The trustees will keep HAEUK's 5 Year Strategic Plan under review and updated.
## **Members' liability**
The Members of the company guarantee to contribute an amount not exceeding £1 to the assets of the company in the event of winding up.
Page 5
**(A company limited by guarantee)**
## **HAEUK**
## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **Statement of Trustees' responsibilities**
The Trustees (who are also the directors of the company for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles of the Charities SORP (FRS 102);
- make judgments and accounting estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of Trustees on and signed on theirJun 27, 2024 behalf by: _________________________________________________
Ann Marie Harding Ann Marie Harding (Jun 27, 2024 15:01 GMT+1)
**Ann Marie Harding** (Chair of Trustees)
Page 6
**(A company limited by guarantee)**
## **HAEUK**
## **INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **Independent examiner's report to the Trustees of HAEUK ('the company')**
I report to the charity Trustees on my examination of the accounts of the company for the year ended 30 September 2023.
## **Responsibilities and basis of report**
As the Trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1. accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the company's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the company's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the company's Trustees as a body, for my work or for this report.
Signed: Dated: 27 June 2024 Graham Hole
## **GMBC LLP**
Chartered Tax Advisers and Accountants Marine House 151 Western Road Haywards Heath West Sussex RH16 3LH
Page 7
**(A company limited by guarantee)**
## **HAEUK**
## **STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 SEPTEMBER 2023**
|**Note**
**Income from:**
Donations and legacies
3
**Total income**
**Expenditure on:**
Raising funds
4
Charitable activities
5
**Total expenditure**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
Net movement in funds
**Total funds carried forward**|**Unrestricted**
**funds**
**2023**
**£**
**108,548**
**108,548**
**-**
**89,031**
**89,031**
**19,517**
**159,037**
**19,517**
**178,554**|**Total**
**funds**
**2023**
**£**
**108,548**
**108,548**
**-**
**89,031**
**89,031**
**19,517**
**159,037**
**19,517**
**178,554**|_Total_
_funds_
_2022_
_£_
_95,158_|
|---|---|---|---|
||||_95,158_|
||||_200_
_88,565_|
||||_88,765_|
||||_6,393_|
||||_152,644_
_6,393_|
||||_159,037_|
The Statement of financial activities includes all gains and losses recognised in the year.
The notes on pages 11 to 21 form part of these financial statements.
Page 8
## **HAEUK (A company limited by guarantee) REGISTERED NUMBER: 08229467**
## **BALANCE SHEET AS AT 30 SEPTEMBER 2023**
|**Note**
**Fixed assets**
Tangible assets
9
**Current assets**
Debtors
10
Cash at bank and in hand
Creditors: amounts falling due within one
year
11
**Net current assets**
**Total assets less current liabilities**
**Total net assets**
**Charity funds**
Restricted funds
13
Unrestricted funds
13
**Total funds**|**-**
**180,868**
**180,868**
**(5,102)**|**2023**
**£**
**2,788**
**2,788**
**175,766**
**178,554**
**178,554**
**-**
**178,554**
**178,554**|_1,362_
_161,079_
_162,441_
_(5,102)_|_2022_
_£_
_1,698_|
|---|---|---|---|---|
|||||_1,698_
_157,339_|
|||||_159,037_|
||||||
|||||_159,037_|
|||||_-_
_159,037_|
||||||
|||||_159,037_|
Page 9
# **HAEUK**
# **(A company limited by guarantee) REGISTERED NUMBER: 08229467**
# **BALANCE SHEET (CONTINUED) AS AT 30 SEPTEMBER 2023**
The company was entitled to exemption from audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.
The financial statements were approved and authorised for issue by the Trustees on andJun 27, 2024 signed on their behalf by: _________________________________________________
Ann Marie Harding Ann Marie Harding (Jun 27, 2024 15:01 GMT+1)
## **Ann Marie Harding**
(Chair of Trustees)
The notes on pages 11 to 21 form part of these financial statements.
Page 10
**HAEUK**
**(A company limited by guarantee)**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **1. General information**
HAEUK is a private company, limited by guarantee, domiciled in England and Wales, registration number 08229467. The registered charity number is 1152591. The registered office of the company is 2 Sheridan Close, Bridgwater, Somerset, TA6 5SN.
## **2. Accounting policies**
## **2.1 Basis of preparation of financial statements**
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
HAEUK meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
## **2.2 Income**
All income is recognised once the company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
## **2.3 Expenditure**
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.
Expenditure is accounted for on an accruals basis and has been included under expense categories that aggregate all costs for allocation to activities.
Expenditure on raising funds includes all expenditure incurred by the company to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the company's objectives, as well as any associated support costs.
All expenditure is inclusive of irrecoverable VAT.
Page 11
**HAEUK**
**(A company limited by guarantee)**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **2. Accounting policies (continued)**
## **2.4 Tangible fixed assets and depreciation**
Tangible fixed assets costing £100 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.
Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.
Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, on a reducing balance basis.
Depreciation is provided on the following basis:
Office equipment - 20%
## **2.5 Debtors**
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
## **2.6 Cash at bank and in hand**
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
## **2.7 Liabilities and provisions**
Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.
Page 12
**(A company limited by guarantee)**
## **HAEUK**
**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **2. Accounting policies (continued)**
## **2.8 Financial instruments**
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
## **2.9 Fund accounting**
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the company and which have not been designated for other purposes.
Page 13
**(A company limited by guarantee)**
## **HAEUK**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **3. Income from donations and legacies**
|**Unrestricted**
**funds**
**2023**
**£**
**Donations**
CSL Behring
35,000
The Anderson Foundation
36,500
Takeda UK
3,000
HAE international
11,712
BioCryst Pharmaceuticals
16,500
**Subtotal detailed disclosure**
102,712
Donations
5,836
**Subtotal**
5,836
**Total 2023**
108,548
_Total 2022_
_95,158_
**4.**
**Expenditure on raising funds**
**Costs of raising voluntary income**|**Total**
**funds**
**2023**
**£**
**35,000**
**36,500**
**3,000**
**11,712**
**16,500**
**102,712**
**5,836**
**5,836**
**108,548**
_95,158_|_Total_
_funds_
_2022_
_£_
_36,500_
_35,125_
_10,000_
_7,669_
_500_|
|---|---|---|
|||_89,794_|
|||_5,364_|
|||_5,364_|
||||
|||_95,158_|
||||
|**Unrestricted**
**funds**
**2023**
**£**
Quiz days expenses
-
_Total 2022_
_200_|**Total**
**funds**
**2023**
**£**
**-**
_200_|_Total_
_funds_
_2022_
_£_
_200_|
|---|---|---|
||||
Page 14
**(A company limited by guarantee)**
## **HAEUK**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **5. Analysis of expenditure on charitable activities**
## **Summary by fund type**
|**Unrestricted**
**funds**
**2023**
**£**
Support and education to help sufferers of Hereditary
Angioedema in the UK
89,031
_Total 2022_
_88,565_|**Total**
**2023**
**£**
**89,031**
_88,565_|_Total_
_2022_
_£_
_88,565_|
|---|---|---|
||||
## **6. Analysis of expenditure by activities**
|Support and education to help sufferers of
Hereditary Angioedema in the UK
_Total 2022_|**Activities**
**undertaken**
**directly**
**2023**
**£**
16,367
_34,893_|**Support**
**costs**
**2023**
**£**
72,664
_53,671_|**Total**
**funds**
**2023**
**£**
**89,031**
_88,564_|_Total_
_funds_
_2022_
_£_
_88,564_|
|---|---|---|---|---|
||||||
Page 15
**HAEUK**
**(A company limited by guarantee)**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **6. Analysis of expenditure by activities (continued)**
## **Analysis of direct costs**
|Patient survey costs
Patient ad boards
Virtual patient days
Research into the lived experience of Hereditary Angioedema
Research Immunology Psychology project
**Total 2023**
_Total 2022_|**Activities**
**2023**
**£**
3,055
-
3,312
-
10,000
16,367
_34,893_|**Total**
**funds**
**2023**
**£**
**3,055**
**-**
**3,312**
**-**
**10,000**
**16,367**
_34,893_|_Total_
_funds_
_2022_
_£_
_4,349_
_800_
_-_
_9,744_
_20,000_|
|---|---|---|---|
||||_34,893_|
|||||
Page 16
**HAEUK**
**(A company limited by guarantee)**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **6. Analysis of expenditure by activities (continued)**
## **Analysis of support costs**
|**Activities**
**2023**
**£**
Depreciation
697
Professional fee
1,200
Communication costs
396
Website costs
1,172
Postage, printing and stationery
4,871
Travel and subsistence
11,457
Subscription costs
650
CEO consultancy fees
34,375
EO consultancy fees
15,180
Sundry expenses
151
Insurance
280
Accountancy fees
1,087
IT software and consumables
884
Bank fees
30
Design services
234
**Total 2023**
72,664
_Total 2022_
_53,671_
**7.**
**Independent examiner's remuneration**
Fees payable to the company's independent examiner for the independent
examination of the company's annual accounts
Fees payable to the company's independent examiner in respect of:
All other services not included above|**Total**
**funds**
**2023**
**£**
**697**
**1,200**
**396**
**1,172**
**4,871**
**11,457**
**650**
**34,375**
**15,180**
**151**
**280**
**1,087**
**884**
**30**
**234**
**72,664**
_53,671_
**2023**
**£**
**870**
**204**|_Total_
_funds_
_2022_
_£_
_424_
_-_
_341_
_1,507_
_428_
_311_
_578_
_33,000_
_14,145_
_336_
_280_
_1,087_
_1,217_
_17_
_-_|
|---|---|---|
|||_53,671_|
|||_2022_
_£_
_870_
_204_|
Page 17
**(A company limited by guarantee)**
## **HAEUK**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **8. Trustees' remuneration and expenses**
During the year ended 30 September 2023, no Trustees received any remuneration or other benefits (2022 - £NIL).
During the year ended 30 September 2023, expenses totalling £519 were reimbursed or paid directly to 5 Trustees. The expenses related to travel cost.
## **9. Tangible fixed assets**
|**Cost or valuation**
At 1 October 2022
Additions
At 30 September 2023
**Depreciation**
At 1 October 2022
Charge for the year
At 30 September 2023
**Net book value**
At 30 September 2023
_At 30 September 2022_
**10.**
**Debtors**
**Due within one year**
Prepayments and accrued income|**2023**
**£**
**-**
**-**|**Office**
**equipment**
**£**
**6,924**
**1,787**|
|---|---|---|
|||**8,711**|
|||**5,226**
**697**|
|||**5,923**|
|||**2,788**|
|||_1,698_|
|||_2022_
_£_
_1,362_
_1,362_|
Page 18
**(A company limited by guarantee)**
## **HAEUK**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **11. Creditors: Amounts falling due within one year**
||**2023**|_2022_|
|---|---|---|
||**£**|_£_|
|Accruals and deferred income|**5,102**|_5,102_|
## **12. Financial instruments**
|**Financial assets**
Financial assets measured at amortised cost
**Financial liabilities**
Financial liabilities measured at amortised cost|**2023**
**£**
**180,868**
**2023**
**£**
**5,102**|_2022_
_£_
_161,079_|
|---|---|---|
|||_2022_
_£_
_5,102_|
Financial assets measured at amortised cost comprises cash at bank and in hand.
Financial liabilities measured at amortised cost comprises accruals.
Page 19
**HAEUK**
**(A company limited by guarantee)**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **13. Statement of funds**
|**Statement of funds - current year**
**Unrestricted funds**
General Funds - all funds
**Statement of funds - prior year**
**Unrestricted funds**
General Funds|**Balance at 1**
**October**
**2022**
**£**
**159,037**
_Balance at_
_1 October_
_2021_
_£_
_152,644_|**Income**
**£**
**108,548**
_Income_
_£_
_95,158_|**Expenditure**
**£**
**(89,031)**
_Expenditure_
_£_
_(88,765)_|**Balance at**
**30**
**September**
**2023**
**£**
**178,554**|
|---|---|---|---|---|
|||||_Balance at_
_30_
_September_
_2022_
_£_
_159,037_|
Page 20
**HAEUK**
**(A company limited by guarantee)**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023**
## **14. Analysis of net assets between funds**
## **Analysis of net assets between funds - current year**
|**Unrestricted**
**funds**
**2023**
**£**
Tangible fixed assets
2,788
Current assets
180,868
Creditors due within one year
(5,102)
**Total**
178,554|**Total**
**funds**
**2023**
**£**
**2,788**
**180,868**
**(5,102)**
**178,554**|
|---|---|
## **Analysis of net assets between funds - prior year**
|Tangible fixed assets
Current assets
Creditors due within one year
**Total**|_Unrestricted_
_funds_
_2022_
_£_
_1,698_
_162,441_
_(5,102)_
_159,037_|_Total_
_funds_
_2022_
_£_
_1,698_
_162,441_
_(5,102)_
_159,037_|
|---|---|---|
Page 21
## HAEUK 2023 Accounts
Final Audit Report
2024-06-27
Created: 2024-06-27 By: Graham Hole (graham@gmbc.uk) Status: Signed Transaction ID: CBJCHBCAABAAxzGyDvkcz0K-eLkiTcEoS4mDR9gR1ieI
## "HAEUK 2023 Accounts" History
Document created by Graham Hole (graham@gmbc.uk) 2024-06-27 - 1:55:03 PM GMT
Document emailed to ann.harding@quattroplant.co.uk for signature
2024-06-27 - 1:56:04 PM GMT
Email viewed by ann.harding@quattroplant.co.uk 2024-06-27 - 1:57:21 PM GMT
Signer ann.harding@quattroplant.co.uk entered name at signing as Ann Marie Harding 2024-06-27 - 2:01:14 PM GMT
Document e-signed by Ann Marie Harding (ann.harding@quattroplant.co.uk) Signature Date: 2024-06-27 - 2:01:16 PM GMT - Time Source: server
Agreement completed.
2024-06-27 - 2:01:16 PM GMT